Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - April 2025

Vendors are growing, and product and service offerings are expanding.

The Hot Market for Cold Chain Services

How artificial intelligence tools are helping to optimize the pharmaceutical transport process.

An AI-Pharma Transport Collaboration

How pharma manufacturers can steadily navigate GTN components and complexities when planning pharmacy benefit reimbursement.

Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit

Videos

Jonathan James, CEO, Hope Charities, discusses the critical importance of maintaining access to life-saving medications for patients with rare diseases to lead productive lives. 

PAP 2025: The Impact of Out-of-Pocket Costs on Patients with Rare Diseases

Articles

The session provides an overview of the uninsured population, and also tackles challenges faced by patients when it comes to accessing PAPs.

PAP 2025: Understanding the Uninsured Landscape

The latest news for pharma industry insiders.

Pharma Pulse 3/20/25: New Ways of Targeting Cancer, How Employers Can Support Employee Well-Being and Mental Health & more

A roundtable explores how patient access needs are being measured, while also discussing the value of affordability in decision-making. 

Access USA 2025: Uncovering Patient Access Complexities

Jonathan James, CEO, Hope Charities, discusses reimbursement challenges and barriers to care in patients requiring life-saving medications. 

PAP 2025: How Charitable Programs Are Evolving to Improve Patient Access to Life-Saving Medications

The conference’s first panel offers insight on the current state of awareness among beneficiaries of the Part D cap and Medicare Prescription Payment Plan via the PAN Foundation’s latest research.

Access USA 2025: Spreading Awareness of Medicare Part D Reforms 

Pharma Pulse 3/19/25: Strategies to Close Women’s Health Innovation Gap, Enhancing Patient Care in Heart Failure–Related Anemia & more

The conference’s opening session highlights the sector’s current landscape of healthcare coverage and access. 

Access USA 2025: This Year’s State of the Industry

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the ways that tariffs disrupt pharma supply chains, along with how leaders can evaluate and prepare for the resulting challenges.

Featured Content

Pharmaceutical Commerce - April 2025

The Hot Market for Cold Chain Services

An AI-Pharma Transport Collaboration

Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit